UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential

Molecular psychiatry, 2018-08, Vol.23 (8), p.1745-1755

2018

Link zum Volltext

Verfügbarkeit prüfen

Blocking CRMP2 SUMOylation reverses neuropathic pain

Molecular psychiatry, 2018-11, Vol.23 (11), p.2119-2121

2018

Link zum Volltext

Verfügbarkeit prüfen

(399) A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses post-operative pain behaviors

The journal of pain, 2015-04, Vol.16 (4), p.S75-S75

2015

Link zum Volltext

Verfügbarkeit prüfen

CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide

Pain (Amsterdam), 2017-12, Vol.158 (12), p.2301-2319

2017

Link zum Volltext

Verfügbarkeit prüfen

CRMP2–Neurofibromin Interface Drives NF1-related Pain

Neuroscience, 2018-06, Vol.381, p.79-90

2018

Link zum Volltext

Verfügbarkeit prüfen

A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function

Channels (Austin, Tex.), 2017-07, Vol.11 (4), p.316-328

2017

Link zum Volltext

Verfügbarkeit prüfen

Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission

Molecular neurobiology, 2019-07, Vol.56 (7), p.5241-5255

2019

Link zum Volltext

Verfügbarkeit prüfen

CRMP2 is necessary for Neurofibromatosis type 1 related pain

Channels (Austin, Tex.), 2018-01, Vol.12 (1), p.47-50

2018

Link zum Volltext

Verfügbarkeit prüfen

Reversal of Peripheral Neuropathic Pain by the Small-Molecule Natural Product Physalin F via Block of CaV2.3 (R-Type) and CaV2.2 (N-Type) Voltage-Gated Calcium Channels

ACS chemical neuroscience, 2019-06, Vol.10 (6), p.2939-2955

2019

Link zum Volltext

Verfügbarkeit prüfen

Genetic and pharmacological antagonism of NK.sub.1 receptor prevents opiate abuse potential

Molecular psychiatry, 2018-08, Vol.23 (8), p.1745

2018

Link zum Volltext

Verfügbarkeit prüfen

SUMO on CRMPs - wrestling for pain?

Channels (Austin, Tex.), 2017-07, Vol.11 (4), p.265-267

2017

Link zum Volltext

Verfügbarkeit prüfen

(−)-Hardwickiic Acid and Hautriwaic Acid Induce Antinociception via Blockade of Tetrodotoxin-Sensitive Voltage-Dependent Sodium Channels

ACS chemical neuroscience, 2019-03, Vol.10 (3), p.1716-1728

2019

Link zum Volltext

Verfügbarkeit prüfen

Genetic and pharmacological antagonism of NK 1 receptor prevents opiate abuse potential

Molecular psychiatry, 2018-08, Vol.23 (8), p.1745

2018

Link zum Volltext

Verfügbarkeit prüfen

Heat shock protein Grp78/BiP/HspA5 binds directly to TDP-43 and mitigates toxicity associated with disease pathology

Scientific reports, 2022-05, Vol.12 (1), p.8140-14, Article 8140

2022

Link zum Volltext

Verfügbarkeit prüfen

Homology‐guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2‐derived peptides

British journal of pharmacology, 2018-06, Vol.175 (12), p.2244-2260

2018

Link zum Volltext

Verfügbarkeit prüfen

The NaV1.8-Collapsin Response Mediator Protein 5 Interaction Regulates NaV1.8 Membrane Localization and Nociception

The journal of pain, 2024-04, Vol.25 (4), p.6-6

2024

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain

Pain (Amsterdam), 2018-10, Vol.159 (10), p.2115-2127

2018

Link zum Volltext

Verfügbarkeit prüfen

Structural Insights Into TDP-43 and Effects of Post-translational Modifications

Frontiers in molecular neuroscience, 2019-12, Vol.12, p.301-301

2019

Link zum Volltext

Verfügbarkeit prüfen

Diffusion NMR in periodic media: efficient computation and spectral properties

Journal of physics. A, Mathematical and theoretical, 2020-08, Vol.53 (32), p.325201

2020

Link zum Volltext

Verfügbarkeit prüfen

Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides

Frontiers in cellular neuroscience, 2015-01, Vol.8, p.471-471

2015

Link zum Volltext

Verfügbarkeit prüfen

Unconventional Signaling by Extracellular CRMP2: Possible Role as an Atypical Neurotransmitter?

Neuroscience, 2018-04, Vol.376, p.224-226

2018

Link zum Volltext

Verfügbarkeit prüfen

The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth

Frontiers in cellular neuroscience, 2014-07, Vol.8, p.196-196

2014

Link zum Volltext

Verfügbarkeit prüfen

Fibroblast Growth Factor Receptor 3 Autoantibodies Induce Hyperexcitability in Sensory Neurons and Pain Behaviors

The journal of pain, 2024-04, Vol.25 (4), p.13-13

2024

Link zum Volltext

Verfügbarkeit prüfen

(S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5

Molecular neurobiology, 2016-04, Vol.53 (3), p.1959-1976

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(110)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(98)
Life Sciences & Biomedicine
(86)
Animals
(62)
Neurosciences
(53)
Neurosciences & Neurology
(52)
Crmp2
(34)
Rats
(32)
Male
(31)
Biochemistry & Molecular Biology
(29)
Rats, Sprague-Dawley
(28)
Female
(25)
Humans
(25)
Clinical Neurology
(22)
Phosphorylation
(22)
Nerve Tissue Proteins - Metabolism
(21)
Pain
(21)
Proteins
(18)
Anesthesiology
(17)
Mice
(17)
Collapsin Response Mediator Protein 2
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential

Blocking CRMP2 SUMOylation reverses neuropathic pain

(399) A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses post-operative pain behaviors

CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide

CRMP2–Neurofibromin Interface Drives NF1-related Pain

A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function

Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission

Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury-associated peripheral sensory neuropathy via block of N- and T-type calcium channels

CRMP2 is necessary for Neurofibromatosis type 1 related pain

Reversal of Peripheral Neuropathic Pain by the Small-Molecule Natural Product Physalin F via Block of CaV2.3 (R-Type) and CaV2.2 (N-Type) Voltage-Gated Calcium Channels

Genetic and pharmacological antagonism of NK.sub.1 receptor prevents opiate abuse potential

SUMO on CRMPs - wrestling for pain?

(−)-Hardwickiic Acid and Hautriwaic Acid Induce Antinociception via Blockade of Tetrodotoxin-Sensitive Voltage-Dependent Sodium Channels

Genetic and pharmacological antagonism of NK 1 receptor prevents opiate abuse potential

Heat shock protein Grp78/BiP/HspA5 binds directly to TDP-43 and mitigates toxicity associated with disease pathology

Homology‐guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2‐derived peptides

The NaV1.8-Collapsin Response Mediator Protein 5 Interaction Regulates NaV1.8 Membrane Localization and Nociception

Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain

Structural Insights Into TDP-43 and Effects of Post-translational Modifications

Diffusion NMR in periodic media: efficient computation and spectral properties

Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides

Unconventional Signaling by Extracellular CRMP2: Possible Role as an Atypical Neurotransmitter?

The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth

Fibroblast Growth Factor Receptor 3 Autoantibodies Induce Hyperexcitability in Sensory Neurons and Pain Behaviors

(S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5

Suchergebnisse filtern